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Abbreviations 
MRI: Magnetic resonance imaging 
plc: Placebo 
pgs: Pentagastrin 
IV: intravenous(ly) 
t50: Half emptying time 
t50_Ghoos: Breath test derived gastric content half emptying time [min] 
t50_MV: MRI derived gastric meal half emptying time [min] 
PDR: Percentage dose recovered [% h-1] 
cPDR: Cumulative percentage dose recovered [%] 
GCV: Gastric content volume [mL] 
MV: Meal volume [mL] 
SV: Secretion volume [mL] 
CA: Contrast agent 
AUC_SV60: Area under the curve of secretion volume during infusion period [mL*min] 
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Abstract 
Background: 
13C-Acetate labeled meals are widely used to determine meal emptying by means of 
analyzing resulting 13CO2 exhalation dynamics. In contrast to the underlying metabolic 
processes, only few 13C breath test meal emptying studies have focused on intragastric 
processes that may alter 13CO2 exhalation. This work assessed the effect of enhanced 
gastric secretion on the reliability of half emptying time (t50) measurements by 13C-acetate 
breath test. 
Methods: 
13CO2 exhalation data was acquired in a double-blind, randomized, crossover gastric 
emptying study in 12 healthy volunteers receiving either pentagastrin or placebo 
intravenously. The standard method proposed by Ghoos et al. was applied to calculate t50 
(t50_Ghoos) from 13CO2 exhalation data, which was compared and tested for agreement to 
meal half emptying times (t50_MV) from concurrent recorded MRI volume data. In addition, 
the accumulated gastric secretion volumes during infusion as detected by MRI (AUC_SV60) 
were correlated to the corresponding cumulative percent 13C doses recovered (cPDR60). 
Key Results: 
t50_Ghoos and t50_MV showed a linear correlation with a slope of 1.1±0.3 (r2=.67), 
however, a positive offset of 136 min for t50_Ghoos. No correlation was detected between 
AUC_SV60 and cPDR60 (r
2=.11). Both, breath test and MRI, revealed a prolonged t50 under 
pentagastrin infusion with median differences in t50_Ghoos of 45[28-84] min (P=.002) and 
t50_MV of 39[28-52] min (P=.002). 
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Conclusions & Interferences: 
This study suggests that 13CO2 exhalation after ingestion of a 
13C-labeled liquid test meal is 
not affected by stimulated gastric secretion, but is rather reflecting the dynamics of meal or 
caloric emptying from the stomach. 
Keywords: 
13C-acetate breath test; gastric secretion; gastric emptying; magnetic resonance imaging 
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Introduction 
Breath tests by means of stable 13C-isotopes have increasingly gained importance in hepatic 
and gastroenterological functional diagnostics. They are attractive, non-invasive and 
multifunctional tools used for different clinical applications such as the quantification of organ 
functions or the determination of gastrointestinal transport.(1)  
To measure gastric emptying, breath tests with 13C labeled fatty acids, such as 13C-acetate, 
13C-octanoic acid or naturally 13C-enriched Spirulina platensis have been proposed to replace 
radioscintigraphy, which is still the gold standard.(2) Ingested 13C-substrates are emptied 
from the stomach, absorbed in the small intestine, undergo catabolism in the liver, enter the 
body’s bicarbonate pool, and then are excreted as 13CO2 in the breath, where 
13C can finally 
be detected.(2) Assuming that all these steps are intact, the rate-limiting step in this process 
is the gastric emptying. Validation studies have shown, that the performance of breath tests 
is not affected by variation in hepatic fatty acid oxidation(3, 4) or metabolic and absorptive 
changes in critical disease, diabetes mellitus, liver cirrhosis and Crohn`s disease.(5) Further, 
it has been demonstrated that intestinal marker delivery is accurately and promptly reflected 
by 13CO2 exhalation and that 
13CO2 formation is not influenced by calorie dependent digestive 
processes.(6) In contrast, the 13C breath test is not fully validated for intragastric influences 
on 13C-marker metabolism or distribution that could lead to a misinterpretation of gastric 
emptying measurements. Gastric secretion is stimulated by nutrient intake and known to 
influence gastric emptying.(8) Large amounts of gastric secretion may conceivably lead to 
dilution and redistribution of the 13C-acetate within the test meal, presumably resulting in 
alterations of 13CO2 exhalation and thus systematic errors in computed t50. Currently, 
magnetic resonance imaging (MRI) is the only non-invasive gastric emptying measurement 
method to separate meal and secretion from overall gastric content and thus to quantify meal 
emptying, gastric secretion volume and related intragastric distribution and mixing.(6, 9-11)  
This work aimed to investigate the effect of enhanced gastric secretion on the reliability of 
meal emptying measurements by 13C-acetate breath test. To this end, concurrent 
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measurements of 13C exhalation data and of MRI volume data of gastric secretion and meal 
from a recent randomized placebo-controlled cross-over study in subjects with and without 
pentagastrin stimulated gastric secretion were analyzed and compared. 
Kuyumcu et al. 7 
 
Methods 
Ethics 
This analysis used data acquired during a recently published study by Goetze et al.(12)  The 
study was carried out according to Good Clinical Practice and the Declaration of Helsinki. 
The study protocol was approved by the local Ethics Committee and the Swiss national 
agency for therapeutic products (registration numbers 1152 and 2005dr2207). All 
measurements were completed without complications or adverse events.  
Test meal 
A sterilized glucose solution (500 mL, 200 kcal; Fresenius Kabi AG, Stans, Switzerland) was 
mixed homogeneously with 5 g locust bean gum powder (Rapunzel Naturkost AG, Legau, 
Germany). The test meal was labelled with 1200 µmol L-1 of the paramagnetic contrast agent 
Gadolinium-DOTA (Dotarem®, Laboratoire Guerbet, Roissy CDG, France) and 200 mg L-1 of 
[1-13C] sodium acetate (Euriso-Top, Saint-Aubin Cedex, France). The mixture was ingested 
at 37 °C, where it had a viscosity of 202 mPa s-1 and an osmolality of 505 mOsm L-1. 
Volunteers and study design 
Primary outcome of this work was the difference in meal emptying half time between 13C-
acetate breath test and MRI. The sample size of 12 participants was determined based on 
the study of Treier et al.(13), a two-sided 5% significance level and a power of 90% allowing 
for the detection of a difference of 15 mL in gastric secretion volume. Eligible participants 
were healthy adults aged 18 - 55, recruited via public announcement. Exclusion criteria were 
pregnancy and lactation, previous abdominal surgery (except appendectomy), intake of any 
medications apart from oral contraceptives, significant abnormality on a 12-lead ECG, 
claustrophobia and presence of metallic implants, devices or foreign bodies. Twelve healthy 
volunteers (seven male) with a mean age of 28 years (22 - 34 years) and a mean body mass 
index of 23.2 kg m-2 (20.3 - 28.0 kg m-2) were investigated between February and May 2006 
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in a single center, double-blind, randomized, placebo-controlled and cross-over study design. 
Randomization was assured by a computer generated random list and stratified with a 1:1 
allocation using random block sizes of 6. The two study days were separated by 2 - 14 days 
and each subject was investigated after an 8 h fasting period. Either pentagastrin (pgs; 0.6 
µg kg-1 h-1; Cambridge Laboratories, Wallsend, UK) or placebo (plc; sodium chloride 0.9% 
Baxter®; Baxter, Volketswil, Switzerland), was infused intravenously (IV) at time point t=0 min 
for 60 minutes. Volunteers ingested the test meal within 3 - 5 min after IV infusion was 
started. Breath samples were taken in fasting state and then after meal intake at regular time 
intervals until 180 min. Concurrent MRI measurements were performed until 90 minutes after 
meal intake. Heart rate and blood pressure were monitored over the whole study period. 
13C-Acetate breath test and MRI data 
To focus on the effect of stimulated gastric secretion on 13CO2 excretion, this work analyzed 
breath test and MRI data during the pentagastrin study arm only for the IV infusion period, 
i.e. until 60 min. After the end of pentagastrin infusion, MRI volume data showed a change in 
the dynamics of secretion and also for meal emptying and, therefore, standard analytical 
methods could no longer be applied for the entire dataset. 
13C-Acetate breath test data 13CO2/
12CO2 ratios were determined by molecular correlation 
spectroscopy (BreathID, Exalenz, Jerusalem, Israel) approximately once every 3 min with an 
automatic nasal breath sampling device under continuous capnographic control. The results 
were expressed as delta () value per mil and delta over baseline (DOBt=Sample-0).(14) 
DOBt was used to determine the percentage dose of 
13C recovered (PDR [% h-1]) and the 
cumulative PDR (cPDR [%]) at each measurement time point until the end of analysis period 
and if indicated as cPDR60 until the end of IV infusion period.(14-16) According to the 
standard breath test analysis methods described by Ghoos et al.(14), meal emptying was 
quantified from the cPDR data by computing the parameter t50 (i.e. half emptying time) with 
t50_Ghoos = (−1*k-1)*ln(1–2−1/β) using the model cPDR(t) = m*[1-e(-kt)]. Using nonlinear 
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mixed-effect modeling, k and  were determined per subject and per visit whereas m was 
estimated for the population. 
MRI data Magnetic resonance imaging measurements were performed in supine body 
position approximately once every 10 min on a whole-body MRI system (1.5 T Achieva; 
Philips Medical Systems, Best, The Netherlands). Imaging techniques were described 
previously.(6) The secretion volume (SV) and the contrast agent (CA) labelled meal volume 
(MV) were extracted from the previously determined gastric content volume (GCV) according 
to an established and validated procedure.(10, 11) In brief, based on MRI T1 mapping data 
of the GCV and a “calibration curve” that describes the interrelation between the measured 
intragastric T1 values and the CA concentration in MV, the percentage meal volume (%meal) 
was determined for each MR image series recorded. Based on the derived %meal, secretion 
and meal volume were then calculated as MV = GCV*%meal and SV = GCV-MV, 
respectively. Since MV did not show a lag effect, MV data was fitted using a power-
exponential mixed-effect model, MV(t) = MV0*e
-(t/tempt). To allow the comparison with the 
breath data that reflects the emptying of the 13C labeled meal, the half emptying time of MV, 
t50_MV = tempt*ln(2), was calculated. In addition, the area under the curve of SV until end of 
IV infusion period (AUC_SV60) was calculated by the trapezoid method. 
Statistics 
Data processing, statistical analyses and plots were done by R 2.13.1 (R Foundation for 
Statistical Computing, Vienna, Austria) and GraphPad Prism® 5. Nonlinear mixed-effect 
modeling was performed using the nlme function of R.(17) A linear regression model was 
used to test for correlation between t50 values derived from breath test and MRI data, and 
agreement between t50 values visualized by the Bland-Altman plot. All nlme and linear 
regression parameter estimates are given as value  standard error. Effects of pentagastrin 
infusion on half emptying times were compared using paired Wilcoxon signed-rank test and 
differences in t50 between the study arms given as median [95% CI]. Correlation between 
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AUC_SV60 and cPDR60 was determined by linear regression analysis. The significance level 
was set to P=.05. 
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Results 
Breath test and MRI data 
Visual inspection of the data revealed that 13CO2 exhalation measurements, expressed as 
cPDR and PDR, were lower during pentagastrin infusion compared to placebo in the majority 
of the volunteers (figure 1A). Also, concurrent meal volume decrease, as assessed by MRI, 
appeared to be slower and secretion volume larger during pentagastrin infusion compared to 
placebo (figure 1B). Both, breath test and MRI data, showed inter-individual variations 
during both placebo and pentagastrin infusion. 
Fits of cPDR and MV overlaid on the original data are presented in figure 2 A and B, 
respectively. Individual estimates of model parameters are listed in the supplemental material 
table S1. 
Correlation and agreement of breath test and MRI data 
Due to technical difficulties during pentagastrin treatment, breath test data of one volunteer 
was missing and excluded from the analyses.  
Treatment independent, i.e. all data encompassing, half emptying times derived from breath 
test (t50_Ghoos) and treatment independent meal half emptying times derived from MRI 
(t50_MV) showed a linear correlation with a slope of 1.1±0.3 and r2 =.67 (figure 3A). The 
Bland-Altman plot revealed a positive offset of 136 min for t50_Ghoos compared to t50_MV 
(figure 3B). No correlation (r2 =.11) was detected between all data encompassing AUC_SV60 
and cPDR60 (figure 3C) suggesting a negligible influence of gastric secretion on 
13CO2 
exhalation. 
Effect of pentagastrin stimulation on gastric meal emptying half time 
Breath test and MRI data both revealed a longer t50 for the pentagastrin study arm (figure 
4A). Table 1 shows the individual differences in t50 between pentagastrin and placebo. 
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Median [95% CI] differences in t50_Ghoos and t50_MV were 45 min [28-84], P=.002 and 39 
min [28-52], P=.002, respectively (figure 4B). 
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Discussion 
To investigate the effect of enhanced gastric secretion on the reliability of meal emptying 
measurements by 13C-acetate breath test, this work analyzed simultaneously acquired 13C-
acetate breath test data and meal emptying data recorded by MRI. Independent of the 
amount of gastric secretion, a linear correlation for the derived half emptying times (t50) was 
found between both methods and, compared to MRI, a large positive offset in t50 was 
determined for the 13C breath test data analyzed by the method proposed by Ghoos et al.(14) 
As expected, pentagastrin caused a prolongation in meal half emptying times (12, 18), that 
was detected with both methods. The prolongation in 13C-acetate breath test half emptying 
time observed during pentagastrin infusion was comparable to the prolongation detected by 
MRI, further suggesting no confounding effect of gastric secretion on 13CO2 exhalation data. 
 
Currently, MRI is the only method to non-invasively assess gastric secretion volume and 
related distribution and mixing of gastric secretion.(6, 9-11) The applied quantitative MRI 
technique(6, 13) enables the extraction of meal and secretion volume from imaged gastric 
content volume, thus allowing a separate quantification of meal emptying from and secretion 
production into the stomach. MRI detected an onset of different meal emptying and gastric 
secretion dynamics after the end of the pentagastrin infusion period (data not presented 
here). This characteristic of the meal emptying prevented incorporation of the entire dataset 
of the pentagastrin study arm into a standard non-linear mixed effect model analysis. 
Therefore, as already pointed out, analysis of data from the pentagastrin study arm was 
limited to the pentagastrin infusion period. Data from MRI revealed that gastric secretion 
volume was increased by pentagastrin infusion with inter-individual differences. From visual 
inspection of MRI data, the intended secretion stimulating effect was detectable within the 
first 20-30 min after start of infusion (figure 1B), which is in accordance with past findings, 
where an increase in gastric acid output after stimulation with gastrin derivates was seen 
after a comparable period.(19, 20)  
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In all subjects, the detected cumulative 13CO2 exhalation dynamic was more related to the 
meal emptying dynamics than to the integrated volume of gastric secretion (figure 3). Breath 
test derived half emptying times (t50_Ghoos) were well correlated with the MRI derived meal 
half emptying times (t50_MV) (figure 3A), however, exhibited a considerable positive offset 
of 136 min in the Bland-Altman plot (figure 3B). 
Positive offsets in t50 derived by the 13C-acetate breath test have previously been described 
in other comparative imaging studies using ultrasonography and gamma-scintigraphy.(21, 
22) Using the method proposed by Ghoos et al. (14), these studies found mean offsets of 41 
min and 49 min, respectively, in comparable test meals. The authors related their observed 
offset to all required post-gastric processing steps of the 13C-acetate marker preceding 13CO2 
exhalation. In studies comparing 13C-octanoate breath test with gamma-scintigraphy, Lee et 
al.(23) and Choi et al.(24) reported mean positive offsets in emptying half times derived from 
4-hour 13C breath test data of 144 and 69 min, respectively. These studies concluded that the 
offset can partly be assigned to an overestimation of the parameter m which is used for 
calculation of the t50_Ghoos. This parameter m is equivalent to the maximal value of cPDR, 
i.e. cPDR(), and is dependent on the actual shape of the cPDR curve, particularly if a 
plateau in 13CO2 exhalation data has not been reached during the acquisition period. The 
parameter m usually approximates 40-80% of the ingested 13C amount, depending on the 
irreversible non-pulmonary loss of the 13C-atom.(23-25) The limited time window available for 
the analysis during the pentagastrin study arm did not allow for individual estimation of the 
parameter m in the majority of subjects. Therefore, m was determined for the population, 
whereas the parameters k and  were simultaneously fitted for each individual. This 
represents a valid and common approach in pharmacometrics (26, 27) and was here 
performed using the nlme function of the program R. k (the elimination constant of the 13C 
atom in breath) and  (the steepness of the rise of 13CO2 exhalation) depend on the type of 
gastric emptying (e.g. if it is fast, slow). The parameter m depends directly on fixation and 
non-pulmonary loss of the 13C-atom. By determining m only for the population, this parameter 
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was considered a common feature of the study cohort. This simplification was required, and 
may be considered a conservative approach, to allow for robust individual detection of 
changes in  and k and thus reliable statistical comparison of t50_Ghoos between the two 
study arms. This approach was indirectly validated by the fact that it allowed the MRI 
confirmed detection of the pentagastrin induced delay in gastric emptying. The estimation of 
m to 71% lies within the upper range of previously reported values. The shorter cPDR curves 
of the pentagastrin arm caused some overestimation in the population value m, resulting in a 
larger offset for the calculated t50_Ghoos. However, the extent by which the offset in 
t50_Ghoos compared to t50_MV can be explained by the post-gastric metabolic processes 
or may be due to the applied standard analytical “Ghoos” method cannot be clearly deduced 
from this work. It may be suspected that it is also caused to a major part by the “Ghoos” 
method itself. Derivation of t50 by analyzing breath test data with other published methods, 
such as the method published by Bluck (28), did also lead to t50 values that correlated with 
t50_MV, but  showed different systematic offsets in half emptying times. Due to these 
inconsistencies between analysis techniques and the lack of a gold standard, the collected 
13C-acetate breath test data was analyzed using the widely accepted “Ghoos” method that 
has been previously validated for liquid emptying.(21) 
Pentagastrin infusion caused an increase in gastric secretion volume and also in meal 
emptying times (figure 4A). Various mechanisms that explain the observed decrease in meal 
emptying rate can be pursued:  (1) Acidification of the duodenum with pH 1.0 – 2.7 induced a 
rapid increase in CCK plasma concentration which in turn is known to inhibit meal 
emptying.(29-34) (2) Neural reflexes involving acid-sensitive neurons that adjust delivery of 
acidic gastric content into the duodenum in order to balance the level of acid and hence to 
avoid mucosal lesions were triggered.(35) (3) Pentagastrin, irrespective of its secretion 
stimulating properties, may have had an effect on meal emptying by altering proximal gastric 
function, i.e. inducing relaxation of the fundus and increasing gastric wall compliance.(18) 
However, the given data did not allow for robust separation of gastric secretion and/or 
pentagastrin induced effects on meal emptying. To exclude the potentially overwhelming 
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effect of pentagastrin itself on motor inhibition, future studies on this topic should be 
designed using physiologic, non-pharmacologic secretion stimulation. 
Considering that the range of changes in t50_Ghoos is comparable to the range of changes 
in t50_MV between pentagastrin and placebo infusion, it can be assumed that the endocrine 
pentagastrin effect is dominating over the intragastric secretion effect. Both methods 
detected a comparable prolonging effect of pentagastrin infusion on t50 with median [95% 
CI] differences in t50_Ghoos of 45 [28-84] minutes and t50_MV of 37 [28-52] minutes. 
Therefore, it may be speculated that pentagastrin affects the emptying process as a whole 
(and thereby in a more constant manner), whereas secretion might possibly have led to a 
partial or local effect in the stomach (and subsequent on the 13C-marker). This would have 
resulted in a wider range of changes in t50_Ghoos between placebo and pentagastrin 
infusion and could also be another explanation for the missing correlation of AUC_SV60 and 
cPDR60 (figure 3C). Additionally, the comparable prolonging effect of pentagastrin on 
t50_Ghoos clearly demonstrated that a pentagastrin infusion specific effect on post-gastric 
13C metabolism can be excluded.  
Above findings suggest that 13CO2 exhalation after ingestion of a 
13C-acetate labeled liquid 
test meal is not affected by the stimulated gastric secretion volume, but is rather reflecting 
the dynamics of meal or caloric emptying from the stomach. 
 
In conclusion, this study represents another step towards the validation of the 13C-acetate 
breath test for gastric emptying measurements. Even under potent pharmacological 
modulation of gastric secretion, the 13C breath test can reliably detect intra-individual 
differences in meal half emptying times. 
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Table 
Table 1 
Differences between pentagastrin and placebo derived half emptying times in minutes for 
breath test and MRI data. 
Initials Δt50_Ghoos (min) Δt50_MV (min) 
BF 32 53 
CB 45 27 
CH 0 37 
DF 107 36 
DS 95 42 
JS 94 -5 
MF 12 34 
RB 12 68 
RK 102 54 
TB 89 59 
TK 28 31 
 
Kuyumcu et al. 21 
 
Figure legends 
Figure 1: Individual Raw Data 
A Individual PDR (% h-1) and cPDR (%) data during infusion with pentagastrin (black) and 
placebo (grey). PDR was lower after 60 min of pentagastrin infusion in 8 of 11 volunteers; 
cPDR was lower in 7 of 11 volunteers. 
B Individual MV (mL) and SV (mL) data during infusion with pentagastrin (black) and placebo 
(grey). MV decrease during pentagastrin infusion was lower in 7 of 12 volunteers. SV during 
pentagastrin infusion reached higher levels in 8 of 12 volunteers 
Kuyumcu et al. 22 
 
 
Figure 2: Individual Fits 
A Individual results for fitted cPDR (%, line) during infusion with pentagastrin (upper row) and 
placebo (lower row), overlaid on raw data (grey dots). Estimated population parameters with 
standard errors were: m = 71.34±1.04, log κ = −5.2±0.06, log β = 0.56±0.04. 
B Individual results for fitted MV (mL, line) during infusion with pentagastrin (upper row) and 
placebo (lower row), overlaid on raw data (grey dots). Estimated population parameters with 
standard errors were: V0 = 495.9±16.4, tempt = 99.6±8.4. 
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Figure 3: Comparison of breath test and MRI derived data 
A Correlation of t50_Ghoos (min) and t50_MV (min). The linear relationship was t50_Ghoos 
= (126 ± 19) min + (1.1 ± 0.3)*t50_MV, with r2 =.67.  
B The Bland-Altman plot of t50_Ghoos (min) and t50_MV (min). The plot shows an offset of 
136 min for t50_Ghoos with limits of agreement of 67 min.  
C Correlation of AUC_SV60 (mL*min) and cPDR60 (%). The linear relationship was cPDR60 =  
(3566 ± 691) - (131 ± 80)*AUC_SV60, with r
2=.11. 
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Figure 4: Differences in half emptying times (t50) between placebo and pentagastrin 
A Individual differences in t50 and B median and 95% CI of the differences in t50 between 
pentagastrin (pgs) and placebo (plc), as assessed by breath test (t50_Ghoos) and MRI 
(t50_MV). Both figures highlight the wider range found for t50_Ghoos. 
 
